Filing Details

Accession Number:
0001225208-13-012578
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-16 20:18:03
Reporting Period:
2013-05-15
Filing Date:
2013-05-16
Accepted Time:
2013-05-16 20:18:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1438226 W Amy Schulman Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-15 100 $29.45 293,397 No 4 S Direct
Common Stock Disposition 2013-05-15 300 $29.46 293,097 No 4 S Direct
Common Stock Disposition 2013-05-15 805 $29.44 292,292 No 4 S Direct
Common Stock Disposition 2013-05-15 1,956 $29.38 290,336 No 4 S Direct
Common Stock Disposition 2013-05-15 2,005 $29.43 288,331 No 4 S Direct
Common Stock Disposition 2013-05-15 2,259 $29.33 286,072 No 4 S Direct
Common Stock Disposition 2013-05-15 2,400 $29.31 283,672 No 4 S Direct
Common Stock Disposition 2013-05-15 3,592 $29.42 280,080 No 4 S Direct
Common Stock Disposition 2013-05-15 3,800 $29.30 276,280 No 4 S Direct
Common Stock Disposition 2013-05-15 3,802 $29.39 272,478 No 4 S Direct
Common Stock Disposition 2013-05-15 3,807 $29.37 268,671 No 4 S Direct
Common Stock Disposition 2013-05-15 3,999 $29.36 264,672 No 4 S Direct
Common Stock Disposition 2013-05-15 4,500 $29.29 260,172 No 4 S Direct
Common Stock Disposition 2013-05-15 4,701 $29.40 255,471 No 4 S Direct
Common Stock Disposition 2013-05-15 5,268 $29.34 250,203 No 4 S Direct
Common Stock Disposition 2013-05-15 5,700 $29.32 244,503 No 4 S Direct
Common Stock Disposition 2013-05-15 10,408 $29.41 234,095 No 4 S Direct
Common Stock Disposition 2013-05-15 10,598 $29.35 223,497 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Phantom Stock Units SSP Acquisiton 2013-05-15 94 $29.56 94 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,080 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,206 Indirect By Rule 16b-3 Plan
Common Stock 300 Indirect By Spouse
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2013.
  2. The reporting person disclaims beneficial ownership of the shares held by spouse.
  3. Each unit represents one phantom share of common stock.
  4. These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.